# RegASK Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/regask-pte

- Industry: Internet
- Headquarters: Singapore, Singapore
- Website: www.regask.com
- Total disclosed funding: $14M
- Latest round: Series A (Dec 14, 2022)
- Investors on record: 4

## About

Based in Singapore, RegASK Pte. Ltd. delivers advanced AI-driven regulatory intelligence solutions, empowering businesses to effectively navigate complex compliance requirements across various sectors.Founded in 2017 and headquartered in Singapore, RegASK Pte. Ltd. focuses on regulatory intelligence solutions. The company has successfully conducted a total of 3 deals, including its most recent Series A funding round on December 14, 2022, where it raised USD 10.51 mn led by Monograph Capital Partners and participated by Roland Investment Holdings Limited and Sprim Ventures. Caroline Shleifer serves as both CEO and Founder, bringing her expertise from previous ventures to drive the company’s growth.RegASK specializes in AI-driven regulatory intelligence solutions that empower organizations to navigate complex compliance landscapes across various industries. Its core offerings include RegGenius, RegAlerts, and RegInsights, providing actionable insights, expert guidance, and streamlined workflows to mitigate compliance risks. The platform caters to clients in life sciences, pharmaceuticals, medical devices, food and beverages, personal care, and industrial sectors, addressing regulatory challenges and improving operational efficiency across North America, Europe, and Asia-Pacific.In 2023, RegASK reported a revenue of USD 3,559,835, with an EBITDA of USD -2,468,693. The company operates a subscription-based revenue model, allowing clients to access its regulatory intelligence products through annual subscriptions, ensuring a steady revenue stream while delivering value in compliance efforts.Following the Series A funding of USD 10.51 mn raised in December 2022, RegASK aims to enhance its business platform and expand into new industries. The funds will support existing deployments in consumer health, medtech, and food industries, with plans to launch new products and enter additional markets. Specific target regions for expansion will be pursued, leveraging the recent investment to facilitate broader market reach and increased product offerings.

## Funding rounds

- Series A, Dec 14, 2022, $11M — Sprim Ventures, Roland Investment Holdings limited, Monograph Capital
- Seed, Jun 6, 2022, $3M — Albrekca, Sprim Ventures, Roland Investment Holdings limited

## Investors

- Albrekca — Seed
- Sprim Ventures (https://capitalatlas.ai/funds/sprim-ventures) — Seed, Series A
- Roland Investment Holdings limited — Seed, Series A
- Monograph Capital (https://capitalatlas.ai/funds/monograph-capital) — Series A